If needed, the next steps may include additional medications that enhance the effects of first-choice drugs (known as combination therapy)
Experimental models include isolated perfused hearts (Langendorff), ex vivo working heart preparations, in vivo echocardiography with metabolic phenotyping, transgenic models affecting carnitine metabolism (OCTN2 knockout, CPT-I variants), and large animal models of myocardial infarction
By analyzing your hormone and metabolic markers, we create supervised plans to help you restore your physical and cognitive edge
Reading your FTO, GLP1R, MC4R, and TCF7L2 markers characterizes baseline pathway biology, not drug outcomes
placebo, n =60)
Any scientific discussion on this page is limited to research context only and should not be interpreted as a claim of therapeutic, cosmetic, or clinical benefit